Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Phathom Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get PHAT alerts

About Azmi Nabulsi

Azmi Nabulsi is recorded as COO at Phathom Pharmaceuticals, Inc. (PHAT). The newest filing on record that lists Azmi Nabulsi as COO at Phathom Pharmaceuticals, Inc. (PHAT) is dated April 23, 2025. The proxy statement of Phathom Pharmaceuticals, Inc. reports total compensation of $2,714,314 for Azmi Nabulsi in fiscal 2025, including a base salary of $219,750. Disclosed compensation is on record for 7 fiscal years. Azmi Nabulsi has spoken on 1 earnings call across 1 company, most recently for Phathom Pharmaceuticals, Inc. on March 7, 2024. Phathom Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Phathom Pharmaceuticals, Inc. includes Steven Basta (CEO and Board Member), Steven L. Basta (CEO and Board Member), Anthony Guzzo (CFO and Chief Accounting Officer) and 7 others.

Azmi Nabulsi on recent calls

“I mean, we're definitely targeting first line. We're looking at a broader population because remember, this is a Phase II.”
COO, Phathom Pharmaceuticals, Inc. Q4 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at Phathom Pharmaceuticals, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Phathom Pharmaceuticals, Inc. (PHAT) $219,750 $2,714,314
2024 Phathom Pharmaceuticals, Inc. (PHAT) $569,000 $1,566,541
2023 Phathom Pharmaceuticals, Inc. (PHAT) $552,000 $2,035,913
2022 Phathom Pharmaceuticals, Inc. (PHAT) $525,000 $2,762,453
2021 Phathom Pharmaceuticals, Inc. (PHAT) $491,250 $4,321,236
2020 Phathom Pharmaceuticals, Inc. (PHAT) $445,065 $2,364,214
2019 Phathom Pharmaceuticals, Inc. (PHAT) $388,522 $531,029

Recent activity